The Risk for Myocardial Infarction with Cyclooxygenase-2 Inhibitors: A Population Study of Elderly Adults

  1. Linda E. Lévesque, BScPhm, MSc;
  2. James M. Brophy, MD, PhD; and
  3. Bin Zhang, MSc
  1. From McGill University Health Centre, McGill University, Montréal, Québec, Canada.
    1. Figure. AMI = acute myocardial infarction; ICD-9 = International Classification of Diseases, Ninth Revision; NSAID = nonsteroidal anti-inflammatory drug.
      View larger version:
        Figure. AMI = acute myocardial infarction; ICD-9 = International Classification of Diseases, Ninth Revision; NSAID = nonsteroidal anti-inflammatory drug. Flow of study cohort.

      Responses to this article

        • James Brophy
        Ann Intern Med published online October 26, 2009
      • Considering cyclooxygenase-2 inhibitor in other point of view
        • Jeong A Kim and
        • Youn Seon Choi, Dokyung Yoon and Kyung Hwan Cho
        Ann Intern Med published online October 26, 2009
      • The Risk of Myocardial Infarction with Cyclooxygenase-2 Inhibitors
        • Michal R Pijak and
        • Igor Huzicka, Frantisek Gazdik
        Ann Intern Med published online October 26, 2009
      • A new hypothesis for the adverse effects of COX-2 inhibitors
        • Ken Shinmura and
        • Roberto Bolli, Institute of Molecular Cardiology, University of Lousiville
        Ann Intern Med published online October 26, 2009

      Summary for Patients

      « Previous | Next Article »Table of Contents

      This Article

      1. Ann Intern Med April 5, 2005 vol. 142 no. 7 481-489
      1. AbstractFREE
      2. » Figures
      3. Full Text
      4. Full Text (PDF)
        1. Summary for Patients

      Current Issue

      1. November 17, 2009, 151 (10)
      1. Alert me to current issues